[1]CurrentPatentAssignee:FORMATHERAPEUTICS,INC.-WO2020/72964,2020,A1Locationinpatent:Paragraph00183;00220;00227-00228
1000576-83-9
1000796-62-2
1000870-15-4
1004538-34-4
1018443-32-7
1020571-45-2
52311-59-8 | 1-(Bromomethyl)-4-chloro-2-nitrobenzene | AA00DBH3 | MFCD09745269
502496-35-7 | 2-Chloro-4-fluoro-6-nitrotoluene | AA00DBNM | MFCD03094191
53827-53-5 | 6-Methyl-1,3-benzothiazol-2-ol | AA00DBV1 | MFCD07783785
473895-88-4 | 2-(Quinoxalin-6-yl)ethanol | AA00DC2T | MFCD12827762
537050-11-6 | 2-Fluoro-3-(trifluoromethyl)phenacyl bromide | AA00DC7A | MFCD03094504
5408-04-8 | Ethyl-2-(hydroxyimino)-3-oxobutanoate | AA00DCIA | MFCD00039517
53355-29-6 | Methyl 4-(5-formylfuran-2-yl)benzoate | AA00DCLS | MFCD00439546
53393-11-6 | N-BENZYL-N-METHYLTHIOUREA | AA00DCPV | MFCD09055276
52094-94-7 | 2-(2-Chlorophenoxy)propanohydrazide | AA00DCUA | MFCD00216762
501427-93-6 | Neu5Ac alpha(2-6)Gal beta(1-4)GlcNAc-beta-pNP | AA00DCY0 | MFCD15072185